S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 984-989

  Leung, James ^a   Wei, Wei ^a   Liu, Limin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; DNA; NITROSOGLUTATHIONE REDUCTASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE MUTATION; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84877130928     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt031     Document Type: Article

References (51)

1. Loeb,L.A. (2011) Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer, 11, 450-457.
2. Totoki,Y. et al. (2011) High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet., 43, 464-469.
3. Li,M. et al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet., 43, 828-829.
4. Sjöblom,T. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274.
5. Perz,J.F. et al. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol., 45, 529-538.
6. Majano,P.L. et al. (1998) Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J. Clin. Invest., 101, 1343-1352.
7. Kane,J.M. 3rd et al. (1997) Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J. Surg. Res., 69, 321-324.
8. Rahman,M.A. et al. (2001) Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin. Cancer Res., 7, 1325-1332.
9. McNaughton,L. et al. (2002) Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc. Natl Acad. Sci. USA, 99, 17161-17166.
10. Hess,D.T. et al. (2005) Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol., 6, 150-166.
11. Liu,L. et al. (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature, 410, 490-494.
12. Liu,L. et al. (2004) Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell, 116, 617-628.
13. Yang,Z. et al. (2010) Lymphocyte development requires S-nitrosoglutathione reductase. J. Immunol., 185, 6664-6669.
14. Nagai,H. et al. (1997) Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene, 14, 2927-2933.
15. Patil,M.A. et al. (2005) Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis, 26, 2050-2057.
16. Wong,N. et al. (1999) Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am. J. Pathol., 154, 37-43.
17. Yeh,S.H. et al. (2001) Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology, 121, 699-709.
18. Wei,W. et al. (2010) S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci. Transl. Med., 2, 19ra13.
19. Hoshida,Y. et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med., 359, 1995-2004.
20. Wei,W. et al. (2011) Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine. Carcinogenesis, 32, 973-977.
21. Liu,R.H. et al. (1991) Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection. Cancer Res., 51, 3925-3929.
22. Gerson,S.L. (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer, 4, 296-307.
23. Lundberg,J.O. et al. (2004) Nitrate, bacteria and human health. Nat. Rev. Microbiol., 2, 593-602.
24. Pegg,A.E. (2000) Repair of O(6)-alkylguanine by alkyltransferases. Mutat. Res., 462, 83-100.
25. Bronstein,S.M. et al. (1992) Efficient repair of O6-ethylguanine, but not O4-ethylthymine or O2-ethylthymine, is dependent upon O6-alkylguanine-DNA alkyltransferase and nucleotide excision repair activities in human cells. Cancer Res., 52, 2008-2011.
26. Iwakuma,T. et al. (1997) High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis, 18, 1631-1635.
27. Nakatsuru,Y. et al. (1993) O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl Acad. Sci. USA, 90, 6468-6472.
28. Zhou,Z.Q. et al. (2001) Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6-methylguanine-DNA methyltransferase. Proc. Natl Acad. Sci. USA, 98, 12566-12571.
29. Tang,C.H. et al. (2012) Regulation of DNA repair by S-nitrosylation. Biochim. Biophys. Acta, 1820, 730-735.
30. Verna,L. et al. (1996) N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther., 71, 57-81.
31. Burney,S. et al. (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res., 424, 37-49.
32. Lambert,I.B. et al. (2005) Detailed review of transgenic rodent mutation assays. Mutat. Res., 590, 1-280.
33. Piegorsch,W.W. et al. (1995) Study design and sample sizes for a lacI transgenic mouse mutation assay. Environ. Mol. Mutagen., 25, 231-245.
34. Kohler,S.W. et al. (1991) Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl Acad. Sci. USA, 88, 7958-7962.
35. Jakubczak,J.L. et al. (1996) Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl Acad. Sci. USA, 93, 9073-9078.
36. Harbach,P.R. et al. (1999) Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice. Environ. Mol. Mutagen., 33, 132-143.
37. Morgan,C. et al. (2006) iMARS-mutation analysis reporting software: an analysis of spontaneous cII mutation spectra. Mutat. Res., 603, 15-26.
38. O'Neill,J.P. (2000) DNA damage, DNA repair, cell proliferation, and DNA replication: how do gene mutations result? Proc. Natl Acad. Sci. USA, 97, 11137-11139.
39. Mientjes,E.J. et al. (1998) DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents. Environ. Mol. Mutagen., 31, 18-31.
40. Madden,C.R. et al. (2001) Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J. Virol., 75, 3851-3858.
41. Vesselinovitch,S.D. et al. (1983) Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res., 43, 4253-4259.
42. Barnes,D.E. et al. (2004) Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet., 38, 445-476.
43. Kim,M.Y. et al. (2012) Delivery method, target gene structure, and growth properties of target cells impact mutagenic responses to reactive nitrogen and oxygen species. Chem. Res. Toxicol., 25, 873-883.
44. Sheh,A. et al. (2010) Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection. Proc. Natl Acad. Sci. USA, 107, 15217-15222.
45. Bronstein,S.M. et al. (1991) Toxicity, mutagenicity, and mutational spectra of N-ethyl-N-nitrosourea in human cell lines with different DNA repair phenotypes. Cancer Res., 51, 5188-5197.
46. Yang,J.L. et al. (1994) Comparison of mutation spectra induced by N-ethyl-N-nitrosourea in the hprt gene of Mer+ and Mer- diploid human fibroblasts. Carcinogenesis, 15, 939-945.
47. Sandercock,L.E. et al. (2008) Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis, 29, 866-874.
48. Beranek,D.T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res., 231, 11-30.
49. Bhanot,O.S. et al. (1992) In vitro DNA replication implicates O2-ethyldeoxythymidine in transversion mutagenesis by ethylating agents. Nucleic Acids Res., 20, 587-594.
50. O'Brien,P.J. et al. (2003) Human alkyladenine DNA glycosylase uses acidbase catalysis for selective excision of damaged purines. Biochemistry, 42, 12418-12429.
51. Bielas,J.H. et al. (2000) Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc. Natl Acad. Sci. USA, 97, 11391-11396.